Stock News and Filings Feed


Add MJN
to your dashboard

MyDx Launches Canadian National Marketing Campaign to Promote Transparency and Prevent Abuse with Its CannaDx Cannabis Handheld Chemical Analyzer

2017-06-15 accesswire
SAN DIEGO, CA / ACCESSWIRE / June 15, 2017 / MyDx, Inc. (OTCQB: MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for the Cannabis professional and retail consumer to correlate the chemical profile of cannabis with the consumers reporting of its therapeutic effect, today announces the deployment of a multi-media marketing campaign across Canada to expand consumer awareness and drive sales.

Cronos Group Provides Operational Update and Files 2016 Financial Results

2017-05-01 marketwired
TORONTO, ON--(Marketwired - May 01, 2017) - Cronos Group Inc. (formerly PharmaCan Capital Corp.) (TSX VENTURE: MJN) ("Cronos" or the "Company") is pleased to report the financial results and accompanying management discussion and analysis for the year ending December 31, 2016; copies are available on the Company's website (www.thecronosgroup.com) and have been filed with SEDAR (www.sedar.com).

Cronos Group Provides Update on Minority Investments

2017-04-24 marketwired
TORONTO, ON--(Marketwired - April 24, 2017) - Cronos Group Inc. (formerly PharmaCan Capital Corp.) (TSX VENTURE: MJN) ("Cronos", or the "Company") is providing an update on its investments in Whistler Medical Marijuana Corporation ("Whistler"), The Hydropothecary Corporation ("Hydropothecary"), ABcann Medicinals Inc. ("ABcann"), Evergreen Medicinal Supply Inc. ("Evergreen"), and CannMart Inc. ("CannMart").

Cronos Announces Re-Filing of Management's Discussion and Analysis for the Period Ended September 30, 2016

2017-03-02 marketwired
TORONTO, ONTARIO--(Marketwired - March 2, 2017) - Cronos Group Inc. (formerly PharmaCan Capital Corp.) (TSX VENTURE:MJN) ("Cronos Group" or the "Company") announces that it has re-filed Management's Discussion and Analysis of financial results for the three and nine months ended September 30, 2016 (the "MD&A") pursuant to a review by staff of the Ontario Securities Commission.

Agritek Holdings, Inc. Announces Plans For Additional Cultivation Property With Licenses In Colorado On Heels of Receiving Listing In First Proposed Cannabis Exchange Fund (ETF)

2017-02-23 marketwired
LOS ANGELES, CA--(Marketwired - Feb 23, 2017) - Agritek Holdings, Inc. (OTC PINK: AGTK), a leader in compassionate care technology and agricultural solutions for the recreational cannabis industry, today announced that the Company has entered into negotiations to purchase an additional thirty-five (35) acre property located in Pueblo county which has already been approved and received licenses for cultivation.

PharmaCan Capital Announces $15 Million Bought Deal

2017-02-14 marketwired
PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE:MJN) ("Cronos" or the "Company") is pleased to announce that it has entered into a letter of engagement with Eight Capital on behalf of a syndicate of underwriters (together, the "Underwriters") under which the Underwriters have agreed to purchase 6,700,000 common shares of the Company (the "Shares"), on a "bought deal" basis pursuant to the filing of a short form prospectus, subject to all required regulatory approvals, at a price per Share of $2.

Reassessing The Ever Changing Outlook For Canadian Cannabis Stocks

2017-01-30 seekingalpha
2017 began on a positive note as expected. The LTB Marijuana Composite Index has gained in six consecutive weeks supported by momentum while the LPs enjoy a well earned rest.

Cronos Calls Shareholder Meeting to Formalize Name Change

2017-01-23 marketwired
TORONTO, ON--(Marketwired - January 23, 2017) - PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) ("Cronos" or the "Company"), seeks shareholder approval to formally change its name to "Cronos Group Inc." following the corporate rebranding announced on October 6, 2016.

Update: My Confidence In Buying Organigram Is Affirmed

2017-01-20 seekingalpha
Organigram's Type II and Type III product recalls have been poorly reported and are misunderstood. The share price is down and this has created a buying opportunity in the stock.

Cronos Applauds German Legalization of Medical Cannabis

2017-01-19 marketwired
TORONTO, ON--(Marketwired - January 19, 2017) - PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) ("Cronos" or the "Company"), is pleased to announce that the German parliament has expanded its medical marijuana program. In a landmark bill, members of Germany's parliament voted unanimously to legalize the use of medical marijuana and have implemented a policy that will provide health insurance coverage for patients with an eligible prescription.

Cronos Group Granted Second Health Canada Sales License

2017-01-11 marketwired
PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) ("Cronos" or the "Company"), is pleased announce that the Company's wholly-owned subsidiary, In the Zone Produce Inc. ("ITZ"), has been approved by Health Canada to sell medicinal cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The new ITZ sales license supplements the prior cultivation license and validates the operational quality assurance undertakings of the Company.

Canadian Cannabis Stocks: 2017 Outlook

2017-01-03 seekingalpha
It was another great year for Canadian cannabis stocks as the LTB Marijuana Composite Index recorded a return of 145.6%, above the three year average of 115.2%.

Cronos Enters Exclusive European Supply Agreement with Pedanios

2016-12-28 marketwired
TORONTO, ON --(Marketwired - December 28, 2016) - PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) ("Cronos" or "the Company"), is pleased to announce the execution of an exclusive supply agreement with German-based Pedanios GmbH ("Pedanios") for the distribution of medical cannabis products in European markets.

It's Time To Buy The Canadian Cannabis Licensed Producers

2016-12-27 seekingalpha
The Canadian Marijuana group and the Licensed Producer sector have both reached a typical buy point based on the magnitude and duration of the correction since the U.S. Presidential election.

7 Winners Identified By The Canadian Cannabis Task Force Report

2016-12-19 seekingalpha
The final report of the Task Force on Marijuana Legalization and Regulation made public last week presents an excellent framework for legalizing cannabis in Canada commencing in spring 2017.

Cronos Embraces Legalization Task Force Report

2016-12-14 marketwired
TORONTO, ON--(Marketwired - December 13, 2016) - PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) ("Cronos" or "the Company"), is pleased with and supportive of the recommendations provided in the report by the Task Force on Cannabis Legalization and Regulation, which outlined the potential framework for the legalization and regulation of cannabis in Canada. A copy of today's report has been posted and is available in the Health section of the Government of Canada's website (http://www.

3 Profitable Ideas For Canadian Cannabis Investors This Week

2016-12-12 seekingalpha
Because the Canadian cannabis stocks have trended lower recently our expectations of a "sell on history" opportunity are now focused on a less severe and shorter selloff.

Phil Fontaine partners with pot producer to help First Nations grow medical marijuana

2016-12-06 globalnews.ca
Sponsored content is written by Global News' editorial staff without any editorial influence by the sponsor. If you'd like to learn more...

Cronos Launches Industry Leading JV With First Nations

2016-12-06 marketwired
PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) ("Cronos" or "the Company"), is pleased to announce the launch of Indigenous Roots, a first-of-its-kind joint venture led by Phil Fontaine, former National Chief of the Assembly of First Nations. Indigenous Roots is a medicinal cannabis company that will work cooperatively with Canadian First Nations towards building and operating licensed facilities and providing medical cannabis to First Nations patients.

Cronos Group Provides Operational Update and Q3 Financial Results

2016-11-29 marketwired
PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) ("Cronos" or the "Company") is pleased to provide the first operational update related to its portfolio of licensed producers ("LPs") and ACMPR applicants since installing new executive management and consolidating our ownership in The Peace Naturals Project Inc. ("Peace Naturals") on September 6, 2016. Cronos also announced its third quarter financial results and accompanying management discussion and analysis for the period ended September 30, 2016; copies of which are available on the Company's website (www.

What American Thanksgiving Revealed About Canadian Cannabis Stocks

2016-11-28 seekingalpha
If Americans accelerated buying Canadian cannabis stocks after the election, the Thanksgiving holiday and a short trading session on Friday should show up as lower volumes on Canadian exchanges.

Cronos Group Grants Stock Options

2016-11-21 marketwired
PharmaCan Capital Corp. doing business as Cronos Group ("Cronos Group" or the "Company") (TSX VENTURE:MJN) announces it has granted options to a consultant to the Company to subscribe to 182,000 common shares of the Company, the whole in accordance with the Company's stock option plan. The options are exercisable at a price of $1.84 per common share, which was the closing price of the Company's common shares on the TSX-V on November 18, 2016.

U.S. Cannabis Stocks Approach A Buy Point As Canadian Marijuana Stocks Near A Sell Point. Get Ready!

2016-11-21 seekingalpha
As expected, the U.S. cannabis stocks dropped more than their Canadian counterparts. American stocks are edging closer to a buy point while the Canadian Licensed Producers approach a sell point.

Cronos Group Enters Agreement With XIB Consulting

2016-11-16 marketwired
PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) ("Cronos" or the "Company"), is pleased to announce that it has entered an engagement agreement with XIB Consulting Inc. ("XIB"), to assist Cronos with business management and corporate development initiatives including, but not limited to, capital allocation, strategic networking and market awareness.

5 Charts Reveal The Current Danger In U.S. Cannabis Stocks

2016-11-14 seekingalpha
In the U.S., the "sell on history" event has occurred as five out of five medical and three out of four recreational legalization votes were approved by voters.